MSD

Pembrolizumab

Biodrugs/ Drugs
Cancer
Pembrolizumab in Subjects with Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL)
2Phase II in Spain, 1Phase I